Washington, DC — The American College of Obstetricians and Gynecologists (The College), along with the American Academy of Pediatrics and the Society for Maternal-Fetal Medicine, is urging Ther-Rx Corporation to reconsider its pricing of Makena™. Makena is the first FDA-approved medication to help prevent preterm birth in certain high-risk pregnant women. The College argues that the extremely high cost of Makena™ will hinder access and affordability to this treatment for both insured and uninsured patients.
To read the full letter, go to http://www.acog.org/from_home/misc/20110311GoedekeLtr.pdf
‘Tis the season to count your blessings. With the holidays fully upon us and Thanksgiving just around the corner, now is an optimal time to consider all we have to be grateful for. But for many, the holiday season can also be a period of stress and sadness — whether you feel overwhelmed with the pressure to host a flawless
While pink ribbons seem to run rampant during the month of October, breast cancer is a topic that should be on our minds 365 days a year — or at least some of those days. The truth? Females in the U.S. have a 12 percent chance of getting breast cancer in their lifetime — that’s one in eight women. That means
Yay! You’re officially “growing a human” — now what? When you’re a new mom-to-be, few things can be as confusing or as daunting as the complex world of pregnancy. But before you start pouring through the pages of your brand-new copy of What to Expect When You’re Expecting, we’ve got answers to some of your most pressing pregnancy questions right